Case Study: Stabilizing IV Supply During Rapid Expansion
A high-volume Medical Center specializing in IV-based therapies during a period of rapid clinical expansion. The client faced an imminent risk of total service stoppage due to supply chain instability.
THE CLIENT
A high-volume Medical Center specializing in IV-based therapies during a period of rapid clinical expansion. The facility operates as a pivotal healthcare hub, providing essential infusion services. To meet rising regional demand, the center undertook an aggressive growth strategy, significantly increasing patient capacity and diversifying its clinical offerings to include specialized IV-based treatments.
The JIT Failure
The organization was operating on a 'Just-in-Time' (JIT) inventory model—a lean strategy that works in stable markets but failed as the global pandemic began. With IV fluids and sets being 'snatched up' by hospital systems and international buyers, the center faced an imminent risk of total service stoppage.
The Action: Strategic Pivot
Partner Diversification
Rapidly onboarded new suppliers while strengthening ties with existing partners to secure 'First-Right' access to allocations during supply disruptions.
Safety Stock Infrastructure
Engineered a customized safety stock model specifically for the IV market, strategically moving from minimal 3-day buffers to robust 30-60-90 day reserves.
Market Intelligence
Monitored raw material and logistics trends to stay 4 weeks ahead of local distributors' stock levels, ensuring proactive rather than reactive procurement.
100%
Service Continuity
While competitors were forced to cancel patient appointments due to fluid shortages, this center avoided stock-outs in their entirety.
Scalability
The new supply chain foundation allowed the center to continue its rapid growth trajectory despite the most volatile market in decades.
Predictable Overhead
Stabilized costs by securing volume commitments before the peak of inflationary price hikes.